Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake ; volume:10 ; number:1 ; day:8 ; month:7 ; year:2020 ; pages:1-12 ; date:12.2020
EJNMMI Research ; 10, Heft 1 (8.7.2020), 1-12, 12.2020
- Urheber
-
Blom, Thomas
Meinsma, Rutger
Rutgers, Marja
Buitenhuis, Corine
Dekken-Van den Burg, Marieke
Kuilenburg, André B. P. van
Tytgat, Godelieve A. M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-020-00662-w
- URN
-
urn:nbn:de:101:1-2020090621360933724817
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blom, Thomas
- Meinsma, Rutger
- Rutgers, Marja
- Buitenhuis, Corine
- Dekken-Van den Burg, Marieke
- Kuilenburg, André B. P. van
- Tytgat, Godelieve A. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake
Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
Molecular studies of ligand binding properties and re-uptake mechanisms at the human and murine serotonin transporter
Myokardialer I-123-Metajodbenzylguanidin (MIBG) Uptake als Zeichen der sympathischen Reinnervation nach Herztransplantation : eine Doppelnuklidstudie mit Thallium-201
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake
Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
Molecular studies of ligand binding properties and re-uptake mechanisms at the human and murine serotonin transporter
Myokardialer I-123-Metajodbenzylguanidin (MIBG) Uptake als Zeichen der sympathischen Reinnervation nach Herztransplantation : eine Doppelnuklidstudie mit Thallium-201
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake
Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
Molecular studies of ligand binding properties and re-uptake mechanisms at the human and murine serotonin transporter